China CDMO (Contract Development & Manufacturing Organization) Industry Research Report, 2018-2021
Table of Contents
1. Overview of Contract Development & Manufacturing Organization
1.2 Mainstream Technologies
1.2.1 Asymmetric synthesis
1.2.2 Cryogenic reaction
1.2.3 Enzymic catalytic reaction
1.2.4 High temperature and high pressure reaction
1.2.5 Crystallization technologies
1.2.6 High activity laboratory
1.3 Industry Chain
2.1 Snapshot of Policies
2.2 Chinese Pharmaceutical Marketing Authorisation Holder System (MAH)
3. Background of CDMO Industry
3.1 Development of Global Pharmaceuticals Industry
The global pharmaceutical industry has huge market space，with stable future growth
Europe and the United States remain the world's largest pharmaceutical market
China's future global market share will gradually increase
Drivers of Global Pharmaceuticals Industry
3.2 Why CDMO？-Reasons for the rise
The R&D cost of new drugs continues to rise while the success rate decreases year by year
Biotech companies are on the rise
Strong returns on patented drugs and pressure on patent expiry have prompted drug companies to step up R&D of new drugs
Chemical drugs remains dominate, the number of micromolecule new drugs is on the rise
3.3 Trends of global pharmaceutical market
The importance of emerging markets are increasing
The share of patented innovative drugs will continue to increase
Innovative biotechnology r&d companies continue to develop
Micromolecule chemical drugs will remain a key area of R&D for some time to come
3.4 Trends of China pharmaceutical market
The popularity of generic drugs has declined and new drugs R&D are on the rise
The pharmaceutical industry has become more innovative and small biotech companies have sprung up
4 CDMO Market
4.1 Entire Pharmaceutical Outsourcing Market
4.2 CRO Market
4.3 CDMO market
4.4 Market Landscape
4.5 Review of CDMO M&A
6 CDMO Players in China
6.1 Asymchem Laboratories (Tianjin) Co., Ltd.
6.2 WuXi Biologics (Cayman) Inc.
6.3 STA Pharmaceutical Co. Ltd.
6.4 Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
6.5 3SBio Inc.
6.5.4 CDMO for antibody drugs
6.6 Porton Fine Chemicals Ltd.
6.7 Lianhe Chemical Technology Co., Ltd.
6.7.2 CDMO Business
6.8 Laviana Pharma Co., Ltd.
6.9 Pharmaron Beijing Co., Ltd.
6.9.3 CDMO Business
6.10 PharmaResources (Shanghai) Co., Ltd.
6.10.2 CDMO Business
6.11 Shanghai ChemPartner Co., Ltd.
6.11.2 CDMO Business
7 Industry Development Trends
7.1 Integrated Industry Chain
Porton Fine Chemicals Ltd.-Expanding CDMO business to upstream CRO business
STA Pharmaceutical Co. Ltd. - Expanding CDMO business to downstream pharmaceutics
7.2 Bio-pharmaceutical CDMO-Main battlefield in the future
List of Charts
Service links of CDMO in pharmaceutical production & research process
Service content of CDMO in pharmaceutical production & research process
Value chain of CDMO Industry
CDMO business models
Policies of China CRO&CDMO Industry, 2010-2017
Global Pharmaceuticals Industry Market Sizez by Segment, 2012-2021E
Global Pharmaceuticals Industry Market Sizez by Region, 2012-2021E
China Pharmaceuticals Industry Market Sizez by Segment, 2012-2021E
The total cost of health care in China，2011-2017
Total global health care costs，2011-2015
The scale of venture capital in China and the global pharmaceutical sector，2013-2016
The average cost of a new drug from development to approval
Cumulative success rate from phase I to phase III of new drug development
The number of drugs at each stage of development, 2016/2017
The number of global biotech IPOs and the amount raised，2011-2015
Number of CDE class I chemical new drugs application, 2013-2017
Number of CDE class I biological new drugs application, 2013-2017
Overview of some IND declaration companies in China
Average NAS sales in the United States after the drug was marketed，1996-2015
Global pipeline for drug development，2001-2017
The number of new drugs approved by FDA, 2001-2017
Number of global micromolecule new drugs under different R&D stages, 2012-2017
Number of micromolecule new drug projects access next stage, 2012-2017
Pineline share of biological and non-biological drugs under R&D, 1995-2017
Global and China pharmaceutical R&D investment, 2012-2021E
Global CRO +CDMO market size, 2012-2021E
China CRO +CDMO market size, 2012-2021E
Global CRO market size, 2012-2021E
China CRO market size, 2012-2021E
Global CDMO market size, 2012-2021E
China CDMO market size, 2012-2021E
Market share of global TOP5 CDMO enterprises, 2017
Regional market share of global CDMO industry, 2017
Global CDMO market relative cost comparison by region
Revenue CAGR of some Global DCMO enterprises, 2013-2017
Market share of Chinese CDMO enterprises, 2017
Revenue CAGR of some Chinese DCMO enterprises, 2013-2017
Capacity of global CMO companies, 2017
Top 2017 CDMO M&A Headlines
Major CDMO market M&A, 2014-2017
Ownership Structure of ASYMCHEM
Business scope of ASYMCHEM
Core technology of ASYMCHEM
R&D investment of ASYMCHEM, 2013-2017
Organization structure of ASYMCHEM Pharmaceutical Science and Technology Institute
Domestic revenue share of ASYMCHEM, 2011-2017
Facilities of ASYMCHEM
Capacity of ASYMCHEM
Revenue structure of ASYMCHEM (by product), 2013-2017
Reserve projects of ASYMCHEM (by product), 2013-2017
Innovative drugs in ASYMCHEM’s commercial projects
Penem antibiotics capacity of Tianjin Asymchem Pharmaceuticals Co., Ltd.
Expansion plan of ASYMCHEM
Capacity addition plan of WuXi Biologics
Backlog increased to US$476mn, with additional US$1.0bn in potential milestones
There has been a constant inflow of projects and customers in the last few months
WuXi Biologics recorded a significant increase in project numbers
Ownership structure of STA Pharmaceutical
Revenue Structure of STA Pharmaceutical (by product), 2012-2017
CDMO business model of STA Pharmaceutical
Production and Sales of Jiuzhou Pharmaceutical’s CDMO business, 2015-2017
CDMO projects of Jiuzhou Pharmaceutical till 2017
History and key milestones of 3SBio Inc.
Key Therapeutic Areas & Capability Focus of 3SBio Inc.
R&D center structure of 3SBio Inc.
R&D platform of 3SBio Inc.
R&D process of 3SBio Inc.
Manufacturing bases of 3SBio Inc.
key information for each production line of 3SBio’s CDMO platform
New drug R&D services of 3SBio’s CDMO platform
CDMO capabilities of 3SBio
Services of Porton by drug life cycle
CDMO revenue of Porton, 2013-2017
Pilot-Scale & Commercial-Scale Manufacture sites of Porton
Pre-production products of Porton’s bio-pharmaceutical CDMO project
Top5 clients of Laviana Pharma, 2015-2017
Ownership structure of Pharmaron
Strucure of Pharmaron’s R&D department
CDMO capacity of Pharmaron, 2015-2017
Services of Pharmaron’s CRO&CDMO business platform
Revenue and gross margin of Pharmaron’s CDMO business, 2015-2017
Number of clients and projects of Pharmaron’s CDMO business, 2015-2017
Ownership structure of PharmaResources
TOP5 Clients of PharmaResources, 2015-2017
CDMO Revenue of PharmaResources, 2015-2017
Classificaiton of Shanghai ChemPartner’s CDMO business
CDMO revenue and gross margin of Shanghai ChemPartner, 2015-2017
Business chain expand of Porton Fine Chemicals Ltd.
Business chain expand of STA Pharmaceutical Co. Ltd.
Bio-pharmaceutical share in global new drugs under R&D, 2012-2017
Competitive landscape of global bio-pharmaceutical market, 2017
Revenue of Samsung Biologics (by business), 2014-2017
Capacity of Samsung Biologics, 2013-2018E (‘0000 litre)
Capacity of Samsung Biologics by plant
Utilisation rate forecasts by each plant of Samsung Biologics, 2014-2022E
Global Viral Conjunctivitis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published: 25-Sep-2018 Price: US 3480 Onwards Pages: 121
Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely to exhibit a thumping CAGR of 69.60% between 2020 and 2023 and reach an opportunity worth US$462.4 mn by the end of the forecast period.
Scope of the Report:
This report f......
Global Vitamin B-complex Ingredients Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published: 25-Sep-2018 Price: US 3480 Onwards Pages: 135
Vitamins are organic compounds that are required by living organisms in minute quantities to maintain a normal metabolic activity. These compounds usually cannot be synthesized by the organism and have to be obtained through external sources. The term "vitamin" is a generic descriptor for a group of chemical compounds or ingredients that have similar molecular structure and have the capability to perform the required vitamin-activity. These chemical compounds or vitamin ingredients are often cal......
Global Secondary Oral Hygiene Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published: 25-Sep-2018 Price: US 3480 Onwards Pages: 137
Secondary oral hygiene can be described as the usage of products for the protection of gums from periodontal diseases. It includes mouthwashes, dental flosses, mouth fresheners, teeth whitening products, and mouth dentures.
Scope of the Report:
This report focuses on the Secondary Oral Hygiene Products in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacture......
Global Vaginal Odor Control Product Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published: 25-Sep-2018 Price: US 3480 Onwards Pages: 101
One of the most commonly occurring and least talked about feminine concerns is vaginal odor. Every woman has a unique scent that fluctuates during her menstrual cycle and may change depending upon hormone levels. The scent originates from vaginal secretions and can vary throughout the month.
Scope of the Report:
This report focuses on the Vaginal Odor Control Product in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East a......
Global Sexual Wellness Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published: 24-Sep-2018 Price: US 3480 Onwards Pages: 136
Sexual wellness refers to the physical, mental, and sexual well-being of people. Products such as erotic lingerie, condoms and contraceptives, personal lubricants, sex toys, and others such as testing cards and pregnancy testing kits, sexual enhancement supplements, sex games, and vaginal sexual wellness products, which enhance safety and pleasure of sexual experiences, are considered sexual wellness products.
Scope of the Report:
This report focuses on the Sexual Wellness ......
Global Etoposide Market Insights, Forecast to 2025
Published: 24-Sep-2018 Price: US 3900 Onwards Pages: 118
This report studies the global market size of Etoposide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Etoposide in these regions.
This research report categorizes the global Etoposide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, ......
Global Oseltamivir Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published: 24-Sep-2018 Price: US 3480 Onwards Pages: 102
Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B (flu).
Scope of the Report:
This report focuses on the Oseltamivir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Oseltamivir is expected to grow at a CAGR of roug......
Global Over The Counter (OTC) Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published: 24-Sep-2018 Price: US 3480 Onwards Pages: 119
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
Scope of the Report:
This report focuses on the Over The Counter (OTC) Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, re......
Global Over the Counter (OTC) Drugs & Dietary Supplements Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published: 24-Sep-2018 Price: US 3480 Onwards Pages: 136
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.
Scope of the Report:......
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details - email@example.com
/ +1 888 391 5441 )
- Ad Hoc
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs